Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Vaccine

• Publication date

  2005-11-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2005.04.047PMID 16011865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

  2005cited by this paper
• A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

  2004cited by this paper
• Selective Modification of Variable Loops Alters Tropism and Enhances Immunogenicity of Human Immunodeficiency Virus Type 1 Envelope

  2004cited by this paper
• Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

  2003cited by this paper
• Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting

  2003cited by this paper
• Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.

  2003cited by this paper
• Control of influenza virus infection by immunity to conserved viral features

  2003cited by this paper
• Multiple T Cell Subsets Control Francisella tularensis LVS Intracellular Growth Without Stimulation Through Macrophage Interferon γ Receptors

  2003cited by this paper
• Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

  2003cited by this paper
• Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

  2003cited by this paper
• Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.

  2003cited by this paper
• DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

  2002cited by this paper
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

  2002cited by this paper
• Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or γδ T Cells1

  2001cited by this paper
• Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

  2001cited by this paper
• Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells.

  2001cited by this paper
• Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection

  2001cited by this paper
• Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

  2001cited by this paper
• Development of a preventive vaccine for Ebola virus infection in primates

  2000cited by this paper
• Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.

  2000cited by this paper
• Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

  2000cited by this paper
• Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

  2000cited by this paper
• Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong

  1999cited by this paper
• A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans

  1999cited by this paper
• Molecular Medicine © 1999 The Picower Institute Press Efficient Generation of Recombinant Adenoviral Vectors by Cre-lox Recombination In Vitro

  1999cited by this paper
• Protective CD4+ and CD8+ T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA

  1998cited by this paper
• Replication-defective adenovirus type 5 as an in vitro and in vivo gene transfer vector in chickens.

  1995cited by this paper
• Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity.

  1994cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Resolution of primary murine listeriosis and acquired resistance to lethal secondary infection can be mediated predominantly by Thy-1+ CD4- CD8- cells.

  1991cited by this paper
• Biological and genetic evolution of the nucleoprotein gene of human influenza A viruses.

  1989cited by this paper
• Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections

  1989cited by this paper
• Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines.

  1988cited by this paper
• Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses.

  1985cited by this paper
• The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak.

  1959cited by this paper

• The protective effect of intranasal immunization with influenza virus recombinant adenovirus vaccine on mucosal and systemic immune response.

  2024cites this paper
• UniFluVec influenza vector induces heterosubtypic protection in ferrets after intranasal administration despite high attenuation

  2024cites this paper
• Development of NP-Based Universal Vaccine for Influenza A Viruses

  2024cites this paper
• A Polysaccharide-Based Oral-Vaccine Delivery System and Adjuvant for the Influenza Virus Vaccine

  2024cites this paper
• The Role of Nucleocapsid Protein (NP) in the Immunology of Crimean–Congo Hemorrhagic Fever Virus (CCHFV)

  2024cites this paper
• A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein

  2024cites this paper
• CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein

  2023cites this paper
• Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions

  2023cites this paper
• Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines

  2023cites this paper
• Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination

  2023cites this paper
• Development of Plant-Based Vaccines for Prevention of Avian Influenza and Newcastle Disease in Poultry

  2022cites this paper
• Influenza B: Prospects for the Development of Cross-Protective Vaccines

  2022cites this paper
• Non-neutralizing antibody responses to vesicular stomatitis virus-vectored influenza A virus vaccines correlate with protection

  2022cites this paper
• A Combination of Recombinant HA1-and Nucleoprotein-Based Chitosan Nanoparticles Induces Early and Potent Immune Responses Against the H9N2 Influenza Virus

  2022cites this paper
• Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies

  2022cites this paper
• Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice

  2022cites this paper
• A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice

  2022cites this paper
• Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model

  2021cites this paper
• Selecting and Using the Appropriate Influenza Vaccine for Each Individual

  2021influential citation
• Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.

  2021cites this paper
• Engineered Influenza Virus Virions Reveal the Contributions of Non-hemagglutinin Structural Proteins to Vaccine-Mediated Protection

  2021cites this paper
• Potentiation of Recombinant NP and M1-Induced Cellular Immune Responses and Protection by Physical Radiofrequency Adjuvant

  2021cites this paper
• A “Prime and Deploy” Strategy for Universal Influenza Vaccine Targeting Nucleoprotein Induces Lung-Resident Memory CD8 T cells

  2021cites this paper
• Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses

  2021cites this paper
• Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses

  2021cites this paper
• Efficacy of recombinant NPM 1 and NPM 1-CRT 3 DNA vaccines against Influenza A viruses in mice 4 C 57 / BL 6 5

  2021cites this paper
• Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus.

  2021cites this paper
• Efficacy of recombinant NP-M1 and NP-M1-CRT DNA vaccines against Influenza A viruses in mice C57/BL6

  2021cites this paper
• T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine

  2021cites this paper
• The Next Generation of Influenza Vaccines: Towards a Universal Solution

  2021cites this paper
• A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice.

  2020cites this paper
• Influenza Chimeric Protein (3M2e-3HA2-NP) Adjuvanted with PGA/Alum Confers Cross-Protection against Heterologous Influenza A Viruses

  2020cites this paper
• Improvement of PR8-Derived Recombinant Clade 2.3.4.4c H5N6 Vaccine Strains by Optimization of Internal Genes and H103Y Mutation of Hemagglutinin

  2020cites this paper
• Design, Cloning, and Expression assay of the NP Gene in a Bicistronic Vector Harboring the Mouse IL-18 Gene: Potential Implications for Type A Influenza Vaccine Investigations

  2020cites this paper
• A review of COVID‐19 vaccines and major considerations for diabetic patients

  2020cites this paper
• Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine

  2020cites this paper
• Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines

  2020cites this paper
• Vaccination of aged mice with adjuvanted recombinant influenza nucleoprotein enhances protective immunity.

  2020cites this paper
• A biomimetic VLP influenza vaccine with interior NP/exterior M2e antigens constructed through a temperature shift-based encapsulation strategy.

  2020cites this paper
• Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice

  2020cites this paper
• ارزیابی پاسخ های ایمنی القاء شده علیه تجویز هم زمان پروتئین نوترکیب NP ویروس آنفلوانزا H1N1 و یاور هموکینین-1 در موش های BALB/c

  2019cites this paper
• Efficient soluble expression and purification of influenza A and B nucleoproteins in E. coli

  2019cites this paper
• Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice

  2019cites this paper
• Evaluation of Immune Responses Induced by Co-administration of Recombinant NP-based Influenza H1N1 Vaccine and Hemokinin-1 Adjuvant in BALB/c Mice

  2019cites this paper
• Development of a Universal Influenza Vaccine

  2019cites this paper
• Immunity to Influenza: Closing in on a Moving Target

  2019cites this paper
• OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes

  2019cites this paper
• The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice

  2019cites this paper
• Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection.

  2018cites this paper
• Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts

  2018cites this paper
• Parainfluenza virus 5–vectored vaccines against human and animal infectious diseases

  2018cites this paper
• Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens

  2018cites this paper
• Epidemiology in History Universal InfluenzaVaccines: Progress inAchievingBroadCross-Protection In Vivo

  2018cites this paper
• Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.

  2018cites this paper
• Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen.

  2018cites this paper
• Influenza vaccines: 'tailor-made' or 'one fits all'.

  2018cites this paper
• Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses.

  2018cites this paper
• Recombinant M2e-HA2 fusion protein induced immunity responses against intranasally administered H9N2 influenza virus.

  2018cites this paper
• Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic

  2017cites this paper
• Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses

  2017cites this paper
• Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice.

  2017cites this paper
• An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice

  2017cites this paper
• Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs

  2017cites this paper
• Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response

  2017cites this paper
• Effects of PB1-F2 and PA-X on the pathogenicity of H1N1 influenza virus

  2017cites this paper
• Vaccine approaches conferring cross-protection against influenza viruses

  2017cites this paper
• Cross-protection by conventional influenza vaccines

  2016cites this paper
• СОВРЕМЕННЫЕ ПОДХОДЫ К СОЗДАНИЮ УНИВЕРСАЛЬНОЙ ВАКЦИНЫ ПРОТИВ ВИРУСА ГРИППА

  2016cites this paper
• Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines

  2016cites this paper
• Viral vector-based influenza vaccines

  2016cites this paper
• Evaluation of Liposome, Heat-Killed Mycobacterium w, and Alum Adjuvants in the Protection Offered by Different Combinations of Recombinant HA, NP proteins, and M2e Against Homologous H5N1 Virus

  2016cites this paper
• Towards the knowledge-based design of universal influenza epitope ensemble vaccines

  2016cites this paper
• Comparison of Five Expression Vectors for the Ha Gene in Constructing a DNA Vaccine for H6N2 Influenza Virus in Chickens

  2016cites this paper
• Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus

  2016cites this paper
• What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins

  2016cites this paper
• Attenuated Strains of Salmonella enterica Serovars Typhi and Paratyphi as Live Oral Vaccines Against Enteric Fever

  2016cites this paper
• Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1.

  2016cites this paper
• High Aspect Ratio Viral Nanoparticles for Cancer Therapy

  2016cites this paper
• Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by Lactobacillus plantarum

  2016cites this paper
• Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection.

  2016influential citation
• The Role of Late Antigen in CD4 Memory T Cell Formation during Influena [i.e. Influenza] Infection: A Dissertation

  2016cites this paper
• Cross-protection by conventional influenza vaccines

  2016cites this paper
• Virus-based nanoparticles as platform technologies for modern vaccines.

  2016cites this paper
• Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice

  2016cites this paper
• Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease

  2016cites this paper
• A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies

  2016cites this paper
• Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge

  2016cites this paper
• Plant molecular farming for the production of industrial enzyme and vaccines

  2015cites this paper
• Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.

  2015cites this paper
• "Quantifizierung infektiöser rekombinanter AAV9-Partikel mittels Real-Time PCR"

  2015cites this paper
• Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies.

  2015cites this paper
• Immunologic Evaluation of DNA Vaccine Encoding Influenza Virus M2 Gene in Type A- Influenza Mice Model

  2015cites this paper
• The reoccurrence of H5N1 outbreaks necessitates the development of safe and effective influenza vaccine technologies for the prevention and control of avian influenza in Sub-Saharan Africa

  2015cites this paper
• Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses

  2015cites this paper
• Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.

  2015cites this paper
• Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice

  2015cites this paper
• Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development.

  2015cites this paper
• Comparison of different ELISA protocols for the detection of IgA against influenza nucleoproteins in trachea of vaccinated chickens.

  2015cites this paper
• Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice

  2015cites this paper
• Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease.

  2015cites this paper